Shu WU

Person

Nanjing, CN

People

Patents Grantslast 30 patents

Information Patent Grant
Antibodies and variants thereof against PD-L1
- Patent number 12,168,688
- Issue date Dec 17, 2024
- Nanjing Legend Biotech Co., Ltd.
- Shuai Yang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Single-domain antibodies against CLL1 and constructs thereof
- Patent number 12,097,219
- Issue date Sep 24, 2024
- Legend Biotech Ireland Limited
- Wang Zhang
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Single-domain antibodies against LAG-3 and uses thereof
- Patent number 11,958,903
- Issue date Apr 16, 2024
- Nanjing Legend Biotech Co., Ltd.
- Wang Zhang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-mesothelin chimeric antigen receptor (CAR) constructs and uses...
- Patent number 11,932,698
- Issue date Mar 19, 2024
- Nanjing Legend Biotech Co., Ltd.
- Qing Dai
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Single-domain antibodies and variants thereof against TIGIT
- Patent number 11,905,327
- Issue date Feb 20, 2024
- Nanjing Legend Biotech Co., Ltd.
- Wang Zhang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Single-domain antibodies and variants thereof against PD-1
- Patent number 11,713,353
- Issue date Aug 1, 2023
- Nanjing Legend Biotech Co., Ltd.
- Yafeng Zhang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Single-domain antibodies and variants thereof against PD-L1
- Patent number 11,673,954
- Issue date Jun 13, 2023
- Nanjing Legend Biotech Co., Ltd.
- Yafeng Zhang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods using a single-domain antibody binding tra...
- Patent number 11,505,601
- Issue date Nov 22, 2022
- Nanjing Legend Biotech Co., Ltd.
- Yafeng Zhang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Single-domain antibodies and variants thereof against CTLA-4
- Patent number 11,472,881
- Issue date Oct 18, 2022
- Nanjing Legend Biotech Co., Ltd.
- Yafeng Zhang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Multispecific antigen binding proteins and methods of use thereof
- Patent number 11,447,573
- Issue date Sep 20, 2022
- Nanjing Legend Biotech Co., Ltd.
- Chuan-Chu Chou
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods for increasing protein half-life in a serum
- Patent number 11,168,146
- Issue date Nov 9, 2021
- Nanjing Legend Biotech Co., Ltd.
- Fang Liang Zhang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compositions and methods for increasing protein half-life in a serum
- Patent number 10,407,508
- Issue date Sep 10, 2019
- Nanjing Legend Biotech., Ltd.
- Fang Liang Zhang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibody humanization by framework assembly
- Patent number 9,090,994
- Issue date Jul 28, 2015
- Nanjingjinsirui Science & Technology Biology Corp.
- Jianbing Zhang
- C40 - COMBINATORIAL CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
MODIFIED IMMUNE CELLS EXPRESSING TLR RECEPTORS
- Publication number 20240350545
- Publication date Oct 24, 2024
- LEGEND BIOTECH IRELAND LIMITED
- Yanliang ZHU
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTIBODIES TARGETING AFP PEPTIDE/MHC COMPLEXES AND USES THEREOF
- Publication number 20240279318
- Publication date Aug 22, 2024
- NANJING LEGEND BIOTECH CO., LTD.
- Mingxin LI
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MUTANT IL-15 COMPOSITIONS AND METHODS THEREOF
- Publication number 20240209050
- Publication date Jun 27, 2024
- LEGEND BIOTECH IRELAND LIMITED
- Ming ZENG
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CHIMERIC CYTOKINE RECEPTORS AND USES THEREOF IN CELLULAR THERAPIES
- Publication number 20240180964
- Publication date Jun 6, 2024
- NANJING LEGEND BIOTECH CO., LTD.
- Qingling JIANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ENGINEERED IMMUNE CELLS AND USES THEREOF
- Publication number 20240150456
- Publication date May 9, 2024
- NANJING LEGEND BIOTECH CO., LTD.
- Fei XU
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SINGLE-DOMAIN ANTIBODIES AND VARIANTS THEREOF AGAINST TIGIT
- Publication number 20240124580
- Publication date Apr 18, 2024
- NANJING LEGEND BIOTECH CO., LTD.
- Wang ZHANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
T CELL AND ANTIGEN-PRESENTING CELL ENGAGERS AND USES THEREOF
- Publication number 20240041924
- Publication date Feb 8, 2024
- NANJING LEGEND BIOTECH CO., LTD.
- Fengyuan TANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ENGINEERING GAMMA DELTA T CELLS WITH INTERLEUKIN-36 FOR IMMUNOTHERAPY
- Publication number 20230338422
- Publication date Oct 26, 2023
- NANJING LEGEND BIOTECH CO., LTD.
- Qingling Jiang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GENETIC ENGINEERING OF gamma delta T CELLS FOR IMMUNOTHERAPY
- Publication number 20230226181
- Publication date Jul 20, 2023
- NANJING LEGEND BIOTECH CO., LTD.
- Zhongyuan Tu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR REDUCING GRAFT REJECTION IN ALLOGENEIC...
- Publication number 20230149461
- Publication date May 18, 2023
- Nanjing Legend Biotech Co., Ltd.
- Zhongyuan TU
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ENGINEERED CELLS AND USES THEREOF
- Publication number 20230144237
- Publication date May 11, 2023
- Nanjing Legend Biotech Co., Ltd.
- Zhongyuan Tu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
GLYPICAN-2-BINDING MOIETIES, CHIMERIC ANTIGEN RECEPTORS AND USES TH...
- Publication number 20230136252
- Publication date May 4, 2023
- NANJING LEGEND BIOTECH CO., LTD.
- Wang Zhang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MULTISPECIFIC ANTIGEN BINDING PROTEINS AND METHODS OF USE THEREOF
- Publication number 20230059836
- Publication date Feb 23, 2023
- NANJING LEGEND BIOTECH CO., LTD.
- Chuan-Chu CHOU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ENGINEERED CELLS AND USES THEREOF
- Publication number 20220265709
- Publication date Aug 25, 2022
- NANJING LEGEND BIOTECH CO., LTD.
- Huihui Zhang
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTI-DLL3 CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF
- Publication number 20220249563
- Publication date Aug 11, 2022
- NANJING LEGEND BIOTECH CO., LTD.
- Tao Zhao
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CD30-BINDING MOIETIES, CHIMERIC ANTIGEN RECEPTORS, AND USES THEREOF
- Publication number 20220144960
- Publication date May 12, 2022
- NANJING LEGEND BIOTECH CO., LTD.
- Shuai Yang
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTIBODIES AND VARIANTS THEREOF AGAINST PD-L1
- Publication number 20220135687
- Publication date May 5, 2022
- Nanjing Legend Biotech Co., Ltd.
- Shuai Yang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MODIFIED IMMUNE CELLS EXPRESSING FLAGELLIN POLYPEPTIDE
- Publication number 20220096547
- Publication date Mar 31, 2022
- Nanjing Legend Biotech Co., Ltd.
- Yafeng ZHANG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITIONS AND METHODS FOR INCREASING PROTEIN HALF-LIFE IN A SERUM
- Publication number 20220033481
- Publication date Feb 3, 2022
- NANJING LEGEND BIOTECH CO., LTD.
- Yafeng ZHANG
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
SINGLE-DOMAIN ANTIBODIES AGAINST CLL1 AND CONSTRUCTS THEREOF
- Publication number 20210277126
- Publication date Sep 9, 2021
- Nanjing Legend Biotech Co., Ltd.
- Wang ZHANG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SINGLE-DOMAIN ANTIBODIES AGAINST CD33 AND CONSTRUCTS THEREOF
- Publication number 20210275590
- Publication date Sep 9, 2021
- Nanjing Legend Biotech Co., Ltd.
- Yafeng ZHANG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CO-RECEPTOR SYSTEMS FOR TREATING INFECTIOUS DISEASES
- Publication number 20210275589
- Publication date Sep 9, 2021
- Nanjing Legend Biotech Co. Ltd.
- Ming Zeng
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-MESOTHELIN CHIMERIC ANTIGEN RECEPTOR (CAR) CONSTRUCTS AND USES...
- Publication number 20210269537
- Publication date Sep 2, 2021
- Nanjing Legend Biotech Co. Ltd.
- Qing DAI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SINGLE-DOMAIN ANTIBODIES AND VARIANTS THEREOF AGAINST PD-L1
- Publication number 20210221891
- Publication date Jul 22, 2021
- Nanjing Legend Biotech Co., Ltd.
- Yafeng ZHANG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-CD47 ANTIBODIES THAT DO NOT CAUSE SIGNIFICANT RED BLOOD CELL A...
- Publication number 20210070855
- Publication date Mar 11, 2021
- Tao Zhao
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SINGLE-DOMAIN ANTIBODIES AND VARIANTS THEREOF AGAINST TIGIT
- Publication number 20210054071
- Publication date Feb 25, 2021
- Wang ZHANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SINGLE-DOMAIN ANTIBODIES AGAINST LAG-3 AND USES THEREOF
- Publication number 20210017279
- Publication date Jan 21, 2021
- Nanjing Legend Biotech Co., Ltd.
- Wang Zhang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MULTISPECIFIC ANTIGEN BINDING PROTEINS AND METHODS OF USE THEREOF
- Publication number 20200369770
- Publication date Nov 26, 2020
- Nanjing Legend Biotech Co., Ltd.
- Yafeng ZHANG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SINGLE-DOMAIN ANTIBODIES AND VARIANTS THEREOF AGAINST PD-1
- Publication number 20200347135
- Publication date Nov 5, 2020
- Nanjing Legend Biotech Co., Ltd.
- Yafeng ZHANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR INCREASING PROTEIN HALF-LIFE IN A SERUM
- Publication number 20190330370
- Publication date Oct 31, 2019
- NANJING LEGEND BIOTECH CO., LTD.
- Fang Liang ZHANG
- C07 - ORGANIC CHEMISTRY

Person

Patents Grantslast 30 patents

Antibodies and variants thereof against PD-L1

Single-domain antibodies against CLL1 and constructs thereof

Single-domain antibodies against LAG-3 and uses thereof

Anti-mesothelin chimeric antigen receptor (CAR) constructs and uses...

Single-domain antibodies and variants thereof against TIGIT

Single-domain antibodies and variants thereof against PD-1

Single-domain antibodies and variants thereof against PD-L1

Compositions and methods using a single-domain antibody binding tra...

Single-domain antibodies and variants thereof against CTLA-4

Multispecific antigen binding proteins and methods of use thereof

Compositions and methods for increasing protein half-life in a serum

Compositions and methods for increasing protein half-life in a serum

Antibody humanization by framework assembly

Patents Applicationslast 30 patents

MODIFIED IMMUNE CELLS EXPRESSING TLR RECEPTORS

ANTIBODIES TARGETING AFP PEPTIDE/MHC COMPLEXES AND USES THEREOF

MUTANT IL-15 COMPOSITIONS AND METHODS THEREOF

CHIMERIC CYTOKINE RECEPTORS AND USES THEREOF IN CELLULAR THERAPIES

ENGINEERED IMMUNE CELLS AND USES THEREOF

SINGLE-DOMAIN ANTIBODIES AND VARIANTS THEREOF AGAINST TIGIT

T CELL AND ANTIGEN-PRESENTING CELL ENGAGERS AND USES THEREOF

ENGINEERING GAMMA DELTA T CELLS WITH INTERLEUKIN-36 FOR IMMUNOTHERAPY

GENETIC ENGINEERING OF gamma delta T CELLS FOR IMMUNOTHERAPY

COMPOSITIONS AND METHODS FOR REDUCING GRAFT REJECTION IN ALLOGENEIC...

ENGINEERED CELLS AND USES THEREOF

GLYPICAN-2-BINDING MOIETIES, CHIMERIC ANTIGEN RECEPTORS AND USES TH...

MULTISPECIFIC ANTIGEN BINDING PROTEINS AND METHODS OF USE THEREOF

ENGINEERED CELLS AND USES THEREOF

ANTI-DLL3 CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF

CD30-BINDING MOIETIES, CHIMERIC ANTIGEN RECEPTORS, AND USES THEREOF

ANTIBODIES AND VARIANTS THEREOF AGAINST PD-L1

MODIFIED IMMUNE CELLS EXPRESSING FLAGELLIN POLYPEPTIDE

COMPOSITIONS AND METHODS FOR INCREASING PROTEIN HALF-LIFE IN A SERUM

SINGLE-DOMAIN ANTIBODIES AGAINST CLL1 AND CONSTRUCTS THEREOF

SINGLE-DOMAIN ANTIBODIES AGAINST CD33 AND CONSTRUCTS THEREOF

CO-RECEPTOR SYSTEMS FOR TREATING INFECTIOUS DISEASES

ANTI-MESOTHELIN CHIMERIC ANTIGEN RECEPTOR (CAR) CONSTRUCTS AND USES...

SINGLE-DOMAIN ANTIBODIES AND VARIANTS THEREOF AGAINST PD-L1

ANTI-CD47 ANTIBODIES THAT DO NOT CAUSE SIGNIFICANT RED BLOOD CELL A...

SINGLE-DOMAIN ANTIBODIES AND VARIANTS THEREOF AGAINST TIGIT

SINGLE-DOMAIN ANTIBODIES AGAINST LAG-3 AND USES THEREOF

MULTISPECIFIC ANTIGEN BINDING PROTEINS AND METHODS OF USE THEREOF

SINGLE-DOMAIN ANTIBODIES AND VARIANTS THEREOF AGAINST PD-1

COMPOSITIONS AND METHODS FOR INCREASING PROTEIN HALF-LIFE IN A SERUM